HEPION PHARMACEUTICALS, INC. Research and Development Expense
HEPION PHARMACEUTICALS, INC. (HEPA) reported Research and Development Expense of $50.92 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-13
- HEPION PHARMACEUTICALS, INC. research and development expense for the quarter ending 2026-06-30 was $50.92K, a 87.97% decline year-over-year.
- HEPION PHARMACEUTICALS, INC. research and development expense for the quarter ending 2026-03-31 was $70.00K, a 214.82% increase year-over-year.
- HEPION PHARMACEUTICALS, INC. research and development expense for the quarter ending 2025-12-31 was $0.00.
- HEPION PHARMACEUTICALS, INC. research and development expense for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- HEPION PHARMACEUTICALS, INC. research and development expense for fiscal 2025 was $445.51K, a 96.24% decline from fiscal 2024.
- HEPION PHARMACEUTICALS, INC. research and development expense for fiscal 2024 was $11.85M, a 66.76% decline from fiscal 2023.
- HEPION PHARMACEUTICALS, INC. research and development expense for fiscal 2023 was $35.64M, a 7.12% increase from fiscal 2022.
- HEPION PHARMACEUTICALS, INC. research and development expense for fiscal 2022 was $33.27M, a 63.12% increase from fiscal 2021.
| Period end | Research and Development Expense 2 month | Research and Development Expense 3 month | Research and Development Expense 5 month | Research and Development Expense 6 month | Research and Development Expense 8 month | Research and Development Expense 9 month | Research and Development Expense 11 month | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $50.92K 10-Q · filed 2026-08-13 | $120.92K 10-Q · filed 2026-08-13 | $120.92K derived: sum of 3 quarters · filed 2026-08-13 | $120.92K derived: sum of 4 quarters · filed 2026-08-13 | |||||
| 2026-03-31 | $70.00K 10-Q · filed 2026-05-14 | $70.00K derived: sum of 2 quarters · filed 2026-05-14 | $70.00K derived: sum of 3 quarters · filed 2026-05-14 | $493.28K derived: sum of 4 quarters · filed 2026-08-13 | |||||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | $423.28K derived: sum of 3 quarters · filed 2026-08-13 | $445.51K 10-K · filed 2026-03-12 | |||||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $423.28K derived: sum of 2 quarters · filed 2026-08-13 | $445.51K 10-Q · filed 2025-11-12 | -$146.10K derived: sum of 4 quarters · filed 2026-08-13 | |||||
| 2025-06-30 | $423.28K 10-Q · filed 2026-08-13 | $445.51K 10-Q · filed 2026-08-13 | -$146.10K derived: sum of 3 quarters · filed 2026-08-13 | $2.62M derived: sum of 4 quarters · filed 2026-08-13 | |||||
| 2025-03-31 | $22.23K 10-Q · filed 2026-05-14 | -$569.37K derived: sum of 2 quarters · filed 2026-05-14 | $2.19M derived: sum of 3 quarters · filed 2026-05-14 | $9.33M derived: sum of 4 quarters · filed 2026-05-14 | |||||
| 2024-12-31 | -$591.61K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $2.17M derived: sum of 2 quarters · filed 2026-03-12 | $9.31M derived: sum of 3 quarters · filed 2026-03-12 | $11.85M 10-K · filed 2026-03-12 | |||||
| 2024-09-30 | $2.76M 10-Q · filed 2025-11-12 | $9.90M derived: sum of 2 quarters · filed 2025-11-12 | $12.44M 10-Q · filed 2025-11-12 | $17.88M derived: sum of 4 quarters · filed 2025-11-12 | |||||
| 2024-06-30 | $7.14M 10-Q · filed 2025-08-14 | $9.68M 10-Q · filed 2025-08-14 | $15.12M derived: sum of 3 quarters · filed 2025-08-14 | $23.64M derived: sum of 4 quarters · filed 2025-08-14 | |||||
| 2024-03-31 | $2.54M 10-Q · filed 2025-05-19 | $7.98M derived: sum of 2 quarters · filed 2025-05-19 | $16.50M derived: sum of 3 quarters · filed 2025-05-19 | $28.38M derived: sum of 4 quarters · filed 2025-05-19 | |||||
| 2023-12-31 | $5.44M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-08 | $13.96M derived: sum of 2 quarters · filed 2025-04-08 | $25.84M derived: sum of 3 quarters · filed 2025-04-08 | $35.64M 10-K · filed 2025-04-08 | |||||
| 2023-09-30 | $8.52M 10-Q · filed 2024-11-14 | $20.40M derived: sum of 2 quarters · filed 2024-11-14 | $30.20M 10-Q · filed 2024-11-14 | $37.71M derived: sum of 4 quarters · filed 2024-11-14 | |||||
| 2023-06-30 | $11.88M 10-Q · filed 2024-08-13 | $21.68M 10-Q · filed 2024-08-13 | $29.19M derived: sum of 3 quarters · filed 2024-08-13 | $34.93M derived: sum of 4 quarters · filed 2024-08-13 | |||||
| 2023-03-31 | $9.80M 10-Q · filed 2024-05-21 | $17.31M derived: sum of 2 quarters · filed 2024-05-21 | $23.05M derived: sum of 3 quarters · filed 2024-05-21 | $38.76M derived: sum of 4 quarters · filed 2024-05-21 | |||||
| 2022-12-31 | $7.52M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $13.26M derived: sum of 2 quarters · filed 2024-04-16 | $28.96M derived: sum of 3 quarters · filed 2024-04-16 | $33.27M 10-K · filed 2024-04-16 | |||||
| 2022-09-30 | $5.74M 10-Q · filed 2023-11-20 | $21.44M derived: sum of 2 quarters · filed 2023-11-20 | $25.75M 10-Q · filed 2023-11-20 | $32.66M derived: sum of 4 quarters · filed 2023-11-20 | |||||
| 2022-06-30 | $15.70M 10-Q · filed 2023-08-14 | $20.01M 10-Q · filed 2023-08-14 | $26.92M derived: sum of 3 quarters · filed 2023-08-14 | $32.72M derived: sum of 4 quarters · filed 2023-08-14 | |||||
| 2022-03-31 | $4.31M 10-Q · filed 2023-05-12 | $11.22M derived: sum of 2 quarters · filed 2023-05-12 | $17.02M derived: sum of 3 quarters · filed 2023-05-12 | $21.21M derived: sum of 4 quarters · filed 2023-05-12 | |||||
| 2021-12-31 | $6.91M derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-10 | $12.71M derived: sum of 2 quarters · filed 2023-04-10 | $16.90M derived: sum of 3 quarters · filed 2023-04-10 | $20.40M 10-K · filed 2023-04-10 | |||||
| 2021-09-30 | $5.80M 10-Q · filed 2022-11-14 | $9.99M derived: sum of 2 quarters · filed 2022-11-14 | $13.49M 10-Q · filed 2022-11-14 | $16.11M derived: sum of 4 quarters · filed 2022-11-14 | |||||
| 2021-06-30 | $4.19M 10-Q · filed 2022-08-15 | $7.68M 10-Q · filed 2022-08-15 | $10.31M derived: sum of 3 quarters · filed 2022-08-15 | $14.09M derived: sum of 4 quarters · filed 2022-08-15 | |||||
| 2021-03-31 | $3.50M 10-Q · filed 2022-05-16 | $6.13M derived: sum of 2 quarters · filed 2022-05-16 | $9.91M derived: sum of 3 quarters · filed 2022-05-16 | $12.86M derived: sum of 4 quarters · filed 2022-05-16 | |||||
| 2020-12-31 | $2.63M derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-08 | $6.41M derived: sum of 2 quarters · filed 2022-04-08 | $9.36M derived: sum of 3 quarters · filed 2022-04-08 | $12.00M 10-K · filed 2022-04-08 | |||||
| 2020-09-30 | $3.78M 10-Q · filed 2021-11-15 | $6.73M derived: sum of 2 quarters · filed 2021-11-15 | $9.37M 10-Q · filed 2021-11-15 | $10.43M derived: sum of 4 quarters · filed 2021-11-15 | |||||
| 2020-06-30 | $2.95M 10-Q · filed 2021-08-16 | $5.59M 10-Q · filed 2021-08-16 | $6.65M derived: sum of 3 quarters · filed 2021-08-16 | $7.50M derived: sum of 4 quarters · filed 2021-08-16 | |||||
| 2020-03-31 | $2.64M 10-Q · filed 2021-05-14 | $3.70M derived: sum of 2 quarters · filed 2021-05-14 | $4.55M derived: sum of 3 quarters · filed 2021-05-14 | $5.30M derived: sum of 4 quarters · filed 2021-05-14 | |||||
| 2019-12-31 | $1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $1.91M derived: sum of 2 quarters · filed 2021-03-31 | $2.67M derived: sum of 3 quarters · filed 2021-03-31 | $3.18M 10-K · filed 2021-03-31 | |||||
| 2019-09-30 | $846.45K 10-Q · filed 2020-11-16 | $1.60M derived: sum of 2 quarters · filed 2020-11-16 | $2.12M 10-Q · filed 2020-11-16 | $3.16M derived: sum of 4 quarters · filed 2020-11-16 | |||||
| 2019-06-30 | $755.66K 10-Q · filed 2020-08-12 | $1.27M 10-Q · filed 2020-08-12 | $2.32M derived: sum of 3 quarters · filed 2020-08-12 | $4.48M derived: sum of 4 quarters · filed 2020-08-12 | |||||
| 2019-03-31 | $518.04K 10-Q · filed 2020-06-29 | $1.56M derived: sum of 2 quarters · filed 2020-06-29 | $3.73M derived: sum of 3 quarters · filed 2020-06-29 | $5.85M derived: sum of 4 quarters · filed 2020-06-29 | |||||
| 2018-12-31 | $1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-14 | $3.21M derived: sum of 2 quarters · filed 2020-05-14 | $5.33M derived: sum of 3 quarters · filed 2020-05-14 | $7.59M 10-K · filed 2020-05-14 | |||||
| 2018-09-30 | $2.17M 10-Q · filed 2019-11-14 | $4.29M derived: sum of 2 quarters · filed 2019-11-14 | $6.55M 10-Q · filed 2019-11-14 | $9.75M derived: sum of 4 quarters · filed 2019-11-14 | |||||
| 2018-06-30 | $2.12M 10-Q · filed 2019-08-14 | $4.38M 10-Q · filed 2019-08-14 | $7.58M derived: sum of 3 quarters · filed 2019-08-14 | $11.55M derived: sum of 4 quarters · filed 2019-08-14 | |||||
| 2018-03-31 | $2.26M 10-Q · filed 2019-05-15 | $5.46M derived: sum of 2 quarters · filed 2019-05-15 | $9.42M derived: sum of 3 quarters · filed 2019-05-15 | $12.68M derived: sum of 4 quarters · filed 2019-05-15 | |||||
| 2017-12-31 | $3.20M derived: 10-K 6 month − 10-Q 3 month · filed 2019-03-14 | $7.16M 10-K · filed 2019-03-14 | $10.42M derived: sum of 3 quarters · filed 2019-03-14 | $13.37M 10-K · filed 2019-03-14 | |||||
| 2017-09-30 | $3.96M 10-Q · filed 2018-11-14 | $7.22M derived: sum of 2 quarters · filed 2018-11-14 | $10.17M 10-Q · filed 2018-11-14 | $14.49M derived: sum of 4 quarters · filed 2018-11-14 | |||||
| 2017-06-30 | $3.26M 10-Q · filed 2018-08-14 | $6.20M 10-Q · filed 2018-08-14 | $10.52M derived: sum of 3 quarters · filed 2018-08-14 | $13.65M 10-K · filed 2019-03-14 | |||||
| 2017-03-31 | $2.94M 10-Q · filed 2018-05-15 | $7.26M derived: sum of 2 quarters · filed 2018-05-15 | $10.39M 10-Q · filed 2017-04-12 | $14.42M derived: sum of 4 quarters · filed 2018-05-15 | |||||
| 2016-12-31 | $4.32M 10-Q · filed 2017-02-14 | $7.45M 10-KT · filed 2018-03-26 | $11.47M derived: sum of 3 quarters · filed 2018-03-26 | $14.66M derived: sum of 4 quarters · filed 2018-03-26 | |||||
| 2016-09-30 | $3.13M 10-Q · filed 2017-11-14 | $7.15M derived: sum of 2 quarters · filed 2018-03-26 | $10.34M derived: sum of 3 quarters · filed 2018-03-26 | $14.38M derived: sum of 4 quarters · filed 2018-03-26 | |||||
| 2016-06-30 | $4.02M derived: 10-KT 12 month − 10-Q 9 month · filed 2018-03-26 | $7.21M derived: sum of 2 quarters · filed 2018-03-26 | $11.25M derived: sum of 3 quarters · filed 2018-03-26 | $15.02M 10-KT · filed 2018-03-26 | $15.02M 10-K · filed 2016-09-28 | ||||
| 2016-03-31 | $3.19M 10-Q · filed 2017-04-12 | $7.23M derived: sum of 2 quarters · filed 2017-04-12 | $10.99M 10-Q · filed 2017-04-12 | $14.58M derived: sum of 4 quarters · filed 2017-04-12 | |||||
| 2015-12-31 | $4.04M 10-Q · filed 2017-02-14 | $7.81M 10-Q · filed 2017-02-14 | $11.40M derived: sum of 3 quarters · filed 2017-02-14 | $14.00M derived: sum of 4 quarters · filed 2017-02-14 | |||||
| 2015-09-30 | $3.77M 10-Q · filed 2016-11-14 | $7.36M derived: sum of 2 quarters · filed 2016-11-14 | $9.96M derived: sum of 3 quarters · filed 2016-11-14 | $11.79M derived: sum of 4 quarters · filed 2016-11-14 | |||||
| 2015-06-30 | $3.59M derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-28 | $6.20M derived: sum of 2 quarters · filed 2016-09-28 | $8.02M derived: sum of 3 quarters · filed 2016-09-28 | $8.40M 10-K · filed 2016-09-28 | |||||
| 2015-03-31 | $2.61M 10-Q · filed 2016-05-13 | $4.43M derived: sum of 2 quarters · filed 2016-05-13 | $4.81M 10-Q · filed 2016-05-13 | $5.03M derived: sum of 4 quarters · filed 2016-05-13 | |||||
| 2014-12-31 | $1.82M 10-Q · filed 2016-02-12 | $2.21M 10-Q · filed 2016-02-12 | $2.43M derived: sum of 3 quarters · filed 2016-02-12 | $2.50M derived: sum of 4 quarters · filed 2016-02-12 | |||||
| 2014-09-30 | $384.06K 10-Q · filed 2015-11-12 | $602.95K derived: sum of 2 quarters · filed 2015-11-12 | $675.46K derived: sum of 3 quarters · filed 2015-11-12 | $684.66K derived: sum of 4 quarters · filed 2015-11-12 | |||||
| 2014-06-30 | $218.89K derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-25 | $291.40K derived: sum of 2 quarters · filed 2015-09-25 | $300.61K derived: sum of 3 quarters · filed 2015-09-25 | $314.25K 10-K · filed 2015-09-25 | |||||
| 2014-03-31 | $72.51K 10-Q · filed 2015-05-14 | $81.72K derived: sum of 2 quarters · filed 2015-05-14 | $95.35K 10-Q · filed 2015-05-14 | $113.09K 10-Q · filed 2014-05-15 | |||||
| 2013-12-31 | $9.21K 10-Q · filed 2015-02-12 | $22.85K 10-Q · filed 2015-02-12 | $40.59K 10-Q · filed 2014-02-05 | ||||||
| 2013-09-30 | $13.64K 10-Q · filed 2014-11-13 | $31.38K 10-Q · filed 2013-11-19 | |||||||
| 2013-06-30 | $122.43K 10-K · filed 2014-09-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |